SLC5A2 and hemorrhagic stroke: Although some cohort studies have shown that an increased hematocrit is associated with a reduced risk of hemorrhagic stroke34,35, current evidence is still uncertain whether the increased hematocrit caused by SGLT2 inhibitors can lower the risk of hemorrhagic stroke.